Sulfated vitamin D metabolites represent prominent roles in serum and in breastmilk of lactating women
Clinical Nutrition · 2024
DOI: 10.1016/j.clnu.2024.07.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition, 2024. Verfasst von Carmen J Reynolds und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Department of Physiology & Biomedical Engineering, USA. Electronic address: reynolds.carmen@mayo.edu. Hauptthemen laut MEDLINE: Lactation, Milk, Human, Dietary Supplements, Vitamin D. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
BACKGROUND: Concentrations of vitamin D (VitD) and 25-hydroxyvitamin D (25OHD) in breastmilk are low despite the essential role of VitD for normal infant bone development, yet additional metabolic forms of vitamin D may be present. This study evaluates the contribution of sulfated vitamin D metabolites, vitamin D3-sulfate (VitD3-S) and 25-hydroxyvitamin D3-sulfate (25OHD3-S) for lactating women and assesses the response to high-dose VitD3 supplementation. METHODS: Serum and breastmilk were measured before and after 28 days with 5000 IU/day VitD3 intake in 20 lactating women. Concentrations of VitD3-S and 25OHD3-S in milk, and 25OHD2, 25OHD3, 25OHD3-S, VitD3 and VitD3-S in serum were determined by mass spectrometry. RESULTS: Baseline vitamin D status was categorized as sufficient (mean ± SD serum 25OHD3 69 ± 19 nmol/L), and both serum VitD3 and 25OHD3 increased following supplementation (p < 0.001). 25OHD3-S was 91 ± 19 nmol/L in serum and 0.47 ± 0.09 nmol/L in breastmilk. VitD3-S concentrations were 2.92 ± 0.70 nmol/L in serum and 6.4 ± 3.9 nmol/L in breastmilk. Neither sulfated metabolite significantly changed with supplementation in either serum or breastmilk. CONCLUSIONS: Sulfated vitamin D metabolites have prominent roles for women during lactation with 25OHD3-S highly abundant in serum and VitD3-S distinctly abundant in breastmilk. These data support the notion that 25OHD3-S and VitD3-S may have physiological relevance during lactation and nutritional usage for nursing infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic Department of Physiology & Biomedical Engineering, USA. Electronic address: reynolds.carmen@mayo.edu.
- Mayo Clinic Immunochemical Core Laboratory, USA.
- Mayo Clinic Department of Family Medicine, USA.
- Mayo Clinic Department of Laboratory Medicine and Pathology, USA.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- Mayo Clinic
- NIDDK
Zitieren
APA
Reynolds, C. J., Dyer, R. B., Oberhelman-Eaton, S. S., Konwinski, B. L., Weatherly, R. M., Singh, R. J., & Thacher, T. D. (2024). Sulfated vitamin D metabolites represent prominent roles in serum and in breastmilk of lactating women. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.07.008
Vancouver
Reynolds CJ, Dyer RB, Oberhelman-Eaton SS, Konwinski BL, Weatherly RM, Singh RJ, et al. Sulfated vitamin D metabolites represent prominent roles in serum and in breastmilk of lactating women. Clinical Nutrition. 2024. doi:10.1016/j.clnu.2024.07.008
BibTeX
@article{Reynolds2024,
author = {Reynolds, Carmen J and Dyer, Roy B and Oberhelman-Eaton, Sara S and Konwinski, Brianna L and Weatherly, Renee M and Singh, Ravinder J and Thacher, Tom D},
title = {Sulfated vitamin D metabolites represent prominent roles in serum and in breastmilk of lactating women},
journal = {Clinical Nutrition},
year = {2024},
doi = {10.1016/j.clnu.2024.07.008}
}
EUVIMED